Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
cardiodx.com

See what CB Insights has to offer

Founded Year

2003

Stage

Dead | Dead

Total Raised

$277M

About CardioDx

CardioDx is a cardiovascular genomic diagnostics company located in Redwood City, California. The company is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, cardiac arrhythmia, and heart failure, CardioDx is poised to expand patient access and improve healthcare quality and efficiency through the commercialization of genomic technologies. CardioDx performs the Corus CAD test in its onsite clinical laboratory which has been certified by the Centers for Medicare and Medicaid Services (CMS) according to the Clinical Laboratory Improvements Amendments (CLIA) and is accredited by the College of American Pathologists (CAP). The CardioDx laboratory is licensed to perform tests for all 50 states.

CardioDx Headquarter Location

600 Saginaw Dr

Redwood City, California, 94063,

United States

650-475-2788

Latest CardioDx News

Former iRhythm, CardioDx Executive Assumes Reimbursement Role at Clarify Medical

May 22, 2020

Former iRhythm, CardioDx Executive Assumes Reimbursement Role at Clarify Medical New recruit has more than 25 years of experience in the medical device industry. Business Wire05.22.20 Clarify Medical  has appointed Linda Kotcher as vice president of Market Access and Reimbursement, effective immediately. Kotcher brings to Clarify Medical over 25 years of healthcare experience in the medical device field with a focus on managed care contracting, provider relations, reimbursement, healthcare policy, and health economics. Most recently, Kotcher served as senior director, U.S. Market Access and Reimbursement, for Heartflow, and previously worked in market access leadership roles at iRhythm, CardioDx, Pathworks Diagnostics, and Dexcom. “Linda’s extensive experience and successful track record of establishing market access for novel medical technologies will undoubtedly bolster our commercialization of the Clarify System,” said George Mahaffey, president and CEO of Clarify Medical. “Because the Clarify System is the only connected and monitored home NB-UVB phototherapy system on the market, we can actually demonstrate improved treatment adherence rates, thereby improving patient outcomes and potentially delaying or avoiding escalation to more expensive therapies. We are pleased to welcome Linda to the team to broaden market access for this new therapeutic option.”   The Clarify System, which has been cleared by the U.S. Food and Drug Administration, is indicated for localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of targeted narrowband UVB (NB-UVB) light therapy; the System helps to ensure that patients receive the proper doses recommended by the American Academy of Dermatology in its published Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis and The Vitiligo Working Group Recommendations for NarrowBand Ultraviolet B Light Phototherapy Treatment of Vitiligo. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer precision treatment and achieve clinical efficacy with narrowband UVB phototherapy in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress and satisfaction. The Clarify smartphone app syncs to a patented, lightweight, handheld device which guides patients through delivering targeted narrowband UVB phototherapy treatments for their specific skin conditions. All treatment records, including photographs and patient—coaching them on the use of the system and encouraging treatment adherence—greatly reducing the burden of these functions on the physician’s practice. “I am excited to join Clarify Medical at this important time in the company’s development,” said Kotcher. “The Clarify System is poised to enable many patients to safely and effectively treat their chronic skin conditions at home, and to drive substantial cost savings by enabling payers and providers to utilize this cost-effective therapy as recommended by the recently published Joint American Academy of Dermatology - National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.” Related Breaking News GlobeNewswire 05.22.20 U.S. Food and Drug Administration 05.22.20 PR Newswire 05.22.20 Business Wire 05.22.20 Roche 05.22.20 Abbott Laboratories 05.22.20 EKF Diagnostics 05.22.20 Purdue University 05.22.20 Business Wire 05.21.20 Globe Newswire 05.21.20 Business Wire 05.21.20 EKF Diagnostics 05.21.20 PR Newswire 05.20.20 Business Wire 05.20.20 Business Wire 05.20.20

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CardioDx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CardioDx is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

M

Medical Devices

7,872 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,392 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

11,260 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

CardioDx Patents

CardioDx has filed 6 patents.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Cardiac procedures
  • Cardiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/15/2010

9/1/2015

Heart diseases, Vascular diseases, Cardiac arrhythmia, Cardiology, Numerical climate and weather models

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/15/2010

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/1/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Heart diseases, Vascular diseases, Cardiac arrhythmia, Cardiology, Numerical climate and weather models

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.